Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. (Q40656844)

22 September 2017

Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. (English)

1 reference

22 September 2017

6

David J Handelsman

1 reference

22 September 2017

Peter Y Liu

1

1 reference

22 September 2017

Val J Gebski

2

1 reference

22 September 2017

Leo Turner

3

1 reference

22 September 2017

Ann J Conway

4

1 reference

22 September 2017

Susan M Wishart

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

22 September 2017

1 reference

22 September 2017

17

1 reference

22 September 2017

625-633

1 reference

22 September 2017

3

1 reference

Gonadotropin Therapy in Men With Isolated Hypogonadotropic Hypogonadism: The Response to Human Chorionic Gonadotropin Is Predicted by Initial Testicular Size

22 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Creutzfeldt-Jakob disease after pituitary gonadotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Gonadotrophin-releasing hormone therapy in hypogonadal males with hypothalamic or pituitary dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Testicular responsiveness to long-term administration of hCG and hMG in patients with hypogonadotrophic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Testicular findings, endocrine features and therapeutic responses of men with acquired hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism--long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2F17.3.625

21 January 2018

Identifiers

DOI

10.1093/HUMREP/17.3.625

1 reference

22 September 2017

1 reference